当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第21期
编号:12959374
甲状腺乳头状癌中TSHR与NIS基因启动子区甲基化状态与侵袭性相关性研究(5)
http://www.100md.com 2016年7月25日 《中国现代医生》 2016年第21期
     [21] Venkataraman GM,Yatin M,Marcinek R. Restoration of iodide uptake in dedifferentiated thyroid carcinoma:Relationship to human Na+/I-symporter gene methylation status[J]. Journal of Clinical Endocrinology and Metabolism,1999,84(7):2449-2457.

    [22] 史晓光,成建新,关海霞,等. 甲状腺乳头状癌中TSHR、NIS 基因甲基化和蛋白表达及其与BRAF突变的关系[J].中国医科大学学报,2009,38(6):401-404.

    [23] Rim H,Mokarram P,Naghibalhossaini F,et al. Impact of BRAF,MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study[J]. Mol Cancer,2008,7:68.

    [24] Santos JC,Bastos AU,Cerutti JM,et al. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma[J]. BMC Cancer,2013,13:79.

    [25] 陆晓筱,葛明华,凌志强,等. 甲状腺乳头状癌中hMLH 1、NIS和TSHR基因异常甲基化的相互关系及临床意义[J].肿瘤,2013,5(33):446-453.

    [26] Ullah Mf,Aatif M. The footprints of cancer development:Cancer biomarkers[J]. Cancer Treat Rev,2009,35(3):193-200.

    [27] Hoque MO,Rosenbaum E,Westra WH,et al. Quantitative assessment of promoter methylation profiles in thyroid neoplasms[J]. J Clin Endocrinol Metab,2005,90(7):4011-4018.

    [28] Riedel C,Lery O&Carrasco N. Post-transcriptional regulation of the sodium/iodide symportor by thyrotropin[J]. Journal of Biological Chemistry,2001,276:21458-21463.

    (收稿日期:2016-05-31), http://www.100md.com(许敬 郭新海 葛明华)
上一页1 2 3 4 5